Bio (NASDAQ:THRD) stock rating was downgraded by Morgan Stanley (NYSE:MS) from Overweight to Equalweight, accompanied by a significant reduction in the price target to $5.00 from the previous $20.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback